These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1580782)

  • 21. Epoetin omega for treatment of anemia in maintenance hemodialysis patients.
    Sikole A; Spasovski G; Zafirov D; Polenakovic M
    Clin Nephrol; 2002 Mar; 57(3):237-45. PubMed ID: 11924756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anemia of chronic renal failure: treatment with erythropoietin.
    Navarro M; Alonso A; Avilla JM; Espinosa L
    Child Nephrol Urol; 1991; 11(3):146-51. PubMed ID: 1777893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical benefits of epoetin alfa (Eprex) 10,000 units subcutaneously thrice weekly in Thai cancer patients with anemia receiving chemotherapy.
    Voravud N; Sriuranpong V
    J Med Assoc Thai; 2005 May; 88(5):607-12. PubMed ID: 16149676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant human erythropoietin therapy in haemodialysis patients--dose determination and clinical experience.
    Bommer J; Alexiou C; Müller-Bühl U; Eifert J; Ritz E
    Nephrol Dial Transplant; 1987; 2(4):238-42. PubMed ID: 3118264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-dose recombinant human erythropoietin for treatment of anemia in myelodysplastic syndromes and paroxysmal nocturnal hemoglobinuria: a pilot study.
    Stebler C; Tichelli A; Dazzi H; Gratwohl A; Nissen C; Speck B
    Exp Hematol; 1990 Dec; 18(11):1204-8. PubMed ID: 2226680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Usefulness of recombinant human erythropoietin on predeposit autologous blood transfusion in patients undergoing radical prostatectomy].
    Hashine K; Karashima T; Kasahara K; Sumiyoshi Y
    Hinyokika Kiyo; 1997 Jun; 43(6):411-4. PubMed ID: 9250490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human recombinant erythropoietin treatment in transfusion dependent anemic patients on maintenance hemodialysis.
    Zehnder C; Blumberg A
    Clin Nephrol; 1989 Feb; 31(2):55-9. PubMed ID: 2920469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Remarkable improvement of anemia by administration of recombinant human erythropoietin in a patient with aplastic anemia].
    Misago M; Mori N; Hoshuyama T; Tsukada J; Morimoto I; Oda S; Chiba S; Eto S
    Rinsho Ketsueki; 1991 Aug; 32(8):912-4. PubMed ID: 1942534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Efficacy of erythropoietin in anemia of patients with immuno-lymphoproliferative disease].
    Longo G; Fiorani C; Bonacorsi G; Vanzanelli P; Sani F; Bevini M; Curci G; Torelli U
    Recenti Prog Med; 1992; 83(7-8):449-54. PubMed ID: 1529159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant human erythropoietin treatment in cisplatin-associated anemia: a randomized, double-blind trial with placebo.
    Cascinu S; Fedeli A; Del Ferro E; Luzi Fedeli S; Catalano G
    J Clin Oncol; 1994 May; 12(5):1058-62. PubMed ID: 8164030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Prevalence of Anemia of Chronic Disease in Patients With Spinal Cord Injuries and Pressure Ulcers and the Impact of Erythropoietin Supplementation on Wound Healing: A Descriptive Pilot Study.
    Vair A; Keast D; LeMesurier A
    Ostomy Wound Manage; 2015 Jun; 61(6):16-26. PubMed ID: 26061404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant erythropoietin for refractory anemia with ring sideroblasts.
    Musto P; Catalano L; Andriani A; Bodenizza C; Cascavilla N; Di Renzo N; Melillo L; Cicoira L; Carotenuto M; Rotoli B
    Haematologica; 1992; 77(2):185-6. PubMed ID: 1398306
    [No Abstract]   [Full Text] [Related]  

  • 33. Recombinant human erythropoietin treatment in elderly cancer patients with cisplatin-associated anemia.
    Cascinu S; Del Ferro E; Fedeli A; Ligi M; Alessandroni P; Catalano G
    Oncology; 1995; 52(5):422-6. PubMed ID: 7637961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of post-traumatic acute anemia by recombinant human erythropoietin in Jehovah's Witnesses].
    Streef C; Charpentier C; Audibert G; Laxenaire MC
    Ann Fr Anesth Reanim; 1996; 15(8):1199-202. PubMed ID: 9636794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of clinical outcomes of different erythropoietin usage strategies.
    Arslan M; Evrensel T; Kurt E; Demiray M; Gonullu G; Kanat O; Manavoglu O
    Tumori; 2004; 90(4):394-8. PubMed ID: 15510982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Erythropoietin is a novel therapeutic option in the treatment of anemia caused by small cell lung cancer].
    Tamási L; Bohács A; Wollák A; Magyar P
    Magy Onkol; 2006; 50(3):243-6. PubMed ID: 17099785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimizing hemoglobin levels and beyond: strength for living and meaningful survival?
    Dicato M
    Oncology; 2005; 68 Suppl 1():1-2. PubMed ID: 15855810
    [No Abstract]   [Full Text] [Related]  

  • 38. Anaemia in patients with traumatic spinal cord injury.
    Perkash A; Brown M
    Paraplegia; 1982 Aug; 20(4):235-6. PubMed ID: 7133754
    [No Abstract]   [Full Text] [Related]  

  • 39. A premature obituary for erythropoietin analogues.
    Steensma DP
    Lancet Oncol; 2008 Apr; 9(4):316. PubMed ID: 18374288
    [No Abstract]   [Full Text] [Related]  

  • 40. Successful treatment of hemosiderosis with regular phlebotomy and recombinant human erythropoietin. Case report and ferrokinetic studies.
    Hotta T; Inoue C; Tsushita K; Miura Y; Saito H
    Acta Haematol; 1991; 86(4):214-6. PubMed ID: 1805491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.